These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1899304)

  • 1. The role of CD4+ and CD8+ T cells in rejection of class I MHC disparate renal allografts.
    Bradley JA; Gracie JA; Porteous C; Bolton EM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):266-7. PubMed ID: 1899304
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts.
    Morton AL; Bolton EM; Lawes CM; Porteous C; Bradley JA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):102-3. PubMed ID: 8438240
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
    Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection.
    Smart YC; Nanra RS; Hibberd AD; Burton RC
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
    Andersen CB; Ladefoged SD; Larsen S
    APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenograft rejection of class I-expressing transgenic skin is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Oct; 22(5):2335-6. PubMed ID: 2120817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients.
    Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
    Stevens HP; Roche N; Hovius SE; Jonker M
    Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
    [No Abstract]   [Full Text] [Related]  

  • 10. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
    [No Abstract]   [Full Text] [Related]  

  • 11. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
    Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
    Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of CD4+ cells to allorejection across a class I major histocompatibility complex barrier in congeneic rats.
    Stepkowski SM; Goto S; Wiggins J; Christopher J; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):172-3. PubMed ID: 1990506
    [No Abstract]   [Full Text] [Related]  

  • 13. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo-in vitro correlates of human rejection using flow cytometry with two-color fluorescence on peripheral blood mononuclear cells.
    Gross U; Thomas F; Matthews C; Thomas J; Cunningham P; Ritter T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1609-10. PubMed ID: 2978885
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
    Gracie JA; Bolton EM; Porteous C; Bradley JA
    J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of T-cell subsets in rat liver allograft rejection.
    Yokoi Y; Sumimoto R; Yamaguchi A; Baba S; Nakamura S; Kimura H
    Transplant Proc; 1993 Apr; 25(2):1994-6. PubMed ID: 8470255
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
    Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
    [No Abstract]   [Full Text] [Related]  

  • 19. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.